PointCheck

DIAGNOSTIC_TEST4 trials

Sponsors

Leuko Labs, Inc.

Conditions

Chemotherapy-induced NeutropeniaDiffuse Large B Cell LymphomaHematologic MalignancyMultiple MyelomaNeoplasmsNeutropenia

Unknown Phase

Study to Evaluate the Usability of PointCheck

CompletedNCT04448314

Leuko Labs, Inc.Chemotherapy-induced Neutropenia, Neoplasms

Start: 2020-02-11End: 2023-06-30Updated: 2023-08-22

PC001- A Study to Evaluate the Usability of PointCheck

CompletedNCT04448301

Leuko Labs, Inc.Neoplasms, Neutropenia

Start: 2021-02-09End: 2025-06-30Updated: 2025-11-06

Usability, Adherence and Diagnostic Performance of PointCheck in Pediatric Population

CompletedNCT04889937

Leuko Labs, Inc.Hematologic Malignancy

Start: 2021-09-07End: 2023-07-31Updated: 2025-03-11

Pivotal Study to Validate a Novel System to Non-Invasively Detect Severe Neutropenia

Active, not recruitingNCT06323447

Leuko Labs, Inc.Diffuse Large B Cell Lymphoma, Multiple Myeloma

Start: 2025-12-15End: 2027-06-30Target: 210Updated: 2026-07-31

Related Papers

Usability Evaluation of a Noninvasive Neutropenia Screening Device (PointCheck) for Patients Undergoing Cancer Chemotherapy: Mixed Methods Observational Study

Journal of Medical Internet Research2022-07-196 citations